ClinicalTrials.gov
public full text
Public Domain
An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD
To evaluate the safety and tolerability of intravitreal injection of LX109 in patients with nAMD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients#1371984
- Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)#892279
- The Efficacy and Safety of Lyoplant® Onlay in Repairing Cerebral Dura Mater#1184689
- Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III#994354
- Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis#1047176
Record · ID 1373130
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive